Julien M Buyck
11PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 17, 2025
Optimizing antimicrobial susceptibility testing: cost and environmental benefits of MIC volume reduction.Jonathan Clarhaut, Jeremy Moreau, Tom Collet
|Apr 14, 2025
PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 Klebsiella pneumoniae isolate.Romain Aubry, Julien M Buyck, Alexia Chauzy
|Sep 11, 2023
Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling.Luc Deroche, Vincent Aranzana-Climent, Albane Rozenholc
|Sep 08, 2023
An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates.Romain Aubry, Julien Buyck, Laure Prouvensier
|Aug 29, 2023
EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption.Miriam Pinilla, Raoul Mazars, Romain Vergé
|Nov 27, 2021
Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin.Chantal Valcourt, Julien M Buyck, Nicolas Grégoire
Pageof 2
Frequent Collaborators
5 joint publications
Sandrine Marchand
2 joint publications
William Couet
2 joint publications
Nicolas Grégoire
1 joint publications
Miriam Pinilla
1 joint publications
Raoul Mazars
1 joint publications
Romain Vergé
1 joint publications
Leana Gorse
1 joint publications
Margaux Paradis
1 joint publications
Bastien Suire
1 joint publications
Karin Santoni
